Survival rates according to barcelona clinic liver cancer sub-staging system after transarterial embolization for intermediate hepatocellular carcinoma

doi:10.4254/wjh.v7.i3.628

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6637)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

524

WORD

199

HTML

3267

Figures (1-1)

204

Tables (1-4)

211

Sum=4405

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

886

Download

1346

Sum=2232

Mar 27, 2015 (publication date) through Oct 31, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Mar 27, 2015; 7(3): 628-632
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.628

Table 1 Barcelona clinic liver cancer B sub-stage categories

	BCLC sub staging
	B1	B2	B3	B4
Child Pugh class	5-6-7	5-6	7	8-9
Beyond Milan and within up-to-7	In	Out	Out	Any
ECOG PS	0	0	0	0-1

BCLC: Barcelona clinic liver cancer; ECOG PS: The Eastern Cooperative Oncology Group performance status.

Citation: Scaffaro LA, Stella SF, Alvares-Da-Silva MR, Kruel CDP. Survival rates according to barcelona clinic liver cancer sub-staging system after transarterial embolization for intermediate hepatocellular carcinoma. World J Hepatol 2015; 7(3): 628-632
URL: https://www.wjgnet.com/1948-5182/full/v7/i3/628.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i3.628